[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07543120":3,"trial-entities:NCT07543120":373,"trial-summary:NCT07543120":376},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":24,"primary_purpose":25,"phases":26,"enrollment_info":28,"interventions":31,"primary_outcomes":36,"secondary_outcomes":41,"sex":50,"minimum_age":51,"maximum_age":52,"healthy_volunteers":53,"eligibility_criteria":54,"std_ages":58,"locations":61,"central_contacts":362,"overall_officials":368,"references":371,"see_also_links":372},"NCT07543120","CQCZ484A12203B","An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.","A Multicenter Open-label Extension Study to Evaluate Long-term Safety and Efficacy of QCZ484 in Hypertensive Patients.","RECRUITING","2031-11-30","2026-07","2026-07-30","2026-05-07","Novartis Pharmaceuticals","INDUSTRY",true,"The purpose of this extension study is to collect additional safety and efficacy on QCZ484 for hypertensive patients who successfully completed the parent study, CQCZ484A12201 or additional QCZ484 studies as specified in the respective parent study protocols.","This is a single arm, multicenter, OLE study designed to evaluate long-term safety, tolerability and efficacy of QCZ484, administered SC, once Q6M, in patients with HTN, who have successfully completed treatment period in the parent studies of the QCZ484 HTN program.\n\nParticipants at sites from the parent study will be offered the option to enroll in this extension study at the Month 12 visit upon successful completion of the parent study treatment.",[19],"Hypertension (HTN)",[21,22,23],"Hypertension","open-label extension study","QCZ484","INTERVENTIONAL","TREATMENT",[27],"PHASE2",{"count":29,"type":30},323,"ESTIMATED",[32],{"type":33,"name":23,"description":34,"armGroupLabels":35},"DRUG","QCZ484 subcutaneous injection, Q6M.",[23],[37],{"measure":38,"description":39,"timeFrame":40},"Number of participants with AEs","Number of participants with Adverse events (AEs), including abnormal safety laboratory parameters and vital signs","Up to 66 months",[42,46],{"measure":43,"description":44,"timeFrame":45},"Change in SBP and DBP assessed by ambulatory blood pressure monitoring","Change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) from Baseline (parent study) and from Day 1 of the OLE and at Months 12 and so on (every 12 months) assessed by assessed by ambulatory blood pressure monitoring (ABPM) - applicable only for the subgroup of participants who had ABPM in the parent study","Baseline (parent study), Day 1 (OLE study) and up to month 60 (OLE study)",{"measure":47,"description":48,"timeFrame":49},"Change in SBP and DBP assessed by office blood pressure measurement","Change in SBP and DBP from Baseline (parent study) and from Day 1 of the OLE and at Months 6, 12 and so on (Q6M) assessed by assessed by office blood pressure measurement (OBPM)","Baseline (parent study), Day 1 (OLE study) and up to month 66 (OLE study)","ALL","18 Years",null,false,{"inclusion":55,"exclusion":56,"raw_text":57},[],[],"Inclusion Criteria:\n\n1. Signed informed consent must be obtained prior to participation in the study.\n2. Successful completion of treatment period on QCZ484 study medication in parent study.\n3. No significant safety issue that may place participant at safety risk as determined by the Investigator.\n\nExclusion Criteria:\n\nParticipants meeting any of the following criteria, may it be pre-existing or developed during the parent study, are not eligible for inclusion in this study:\n\n1. Evidence of hepatic disease that would put participant at risk by taking QCZ484 for long term as determined by the Investigator.\n2. Clinically significant cardiac arrhythmias (e.g., ventricular tachycardia), high-grade atrioventricular (AV) block (e.g., Mobitz type II and third-degree AV block in absence of a pacemaker) developed during the parent study.\n3. Permanent or persistent atrial fibrillation developed during the parent study.\n4. Clinically significant valvular heart disease developed during the parent study.\n5. Acute myocardial infarction (AMI) or unstable angina, or any percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) developed during the parent study. Any history of ischemic or hemorrhagic stroke or transient ischemic attack any time prior to enrollment.\n\nOther protocol-defined inclusion\u002Fexclusion criteria may apply",[59,60],"ADULT","OLDER_ADULT",[62,80,94,108,121,135,148,161,175,190,204,218,232,247,261,276,291,305,320,334,343,347,350,353,359],{"facility":63,"status":8,"city":64,"state":65,"zip":66,"country":67,"contacts":68,"geoPoint":77},"NICRs Research Center","Garden Grove","California","92844","United States",[69,74],{"name":70,"role":71,"phone":72,"email":73},"Maria Murillo","CONTACT","+1 909 206 2454","mmurillo@nicresearch.com",{"name":75,"role":76},"Mallu Reddy","PRINCIPAL_INVESTIGATOR",{"lat":78,"lon":79},33.77391,-117.94145,{"facility":81,"status":8,"city":82,"state":65,"zip":83,"country":67,"contacts":84,"geoPoint":91},"Downtown L A Research Center Inc","Los Angeles","90017",[85,89],{"name":86,"role":71,"phone":87,"email":88},"Claudia Cisneros","+1 213 261 3680","ccisneros@dtlaresearch.com",{"name":90,"role":76},"Salil U Nadkarni",{"lat":92,"lon":93},34.05223,-118.24368,{"facility":95,"status":8,"city":96,"state":97,"zip":98,"country":67,"contacts":99,"geoPoint":105},"Clinical Research of Brandon LLC","Brandon","Florida","33511",[100,103],{"name":101,"role":71,"email":102},"Erika Santos","esantos@crofb.com",{"name":104,"role":76},"German Alvarez",{"lat":106,"lon":107},27.9378,-82.28592,{"facility":109,"status":8,"city":110,"state":97,"zip":111,"country":67,"contacts":112,"geoPoint":118},"Entrust Clinical Research","Miami","33176",[113,116],{"name":114,"role":71,"email":115},"Daimelys Garcia","Dgarcia@entrustclinicalresearch.com",{"name":117,"role":76},"Adolfo Cueli",{"lat":119,"lon":120},25.77427,-80.19366,{"facility":122,"status":8,"city":123,"state":97,"zip":124,"country":67,"contacts":125,"geoPoint":132},"Inpatient Research Clinical LLC","Miami Lakes","33014",[126,130],{"name":127,"role":71,"phone":128,"email":129},"Ilianys Marino","+1 786 502 4303","imarino@inpatientresearch.com",{"name":131,"role":76},"Alexis Gutierrez",{"lat":133,"lon":134},25.90871,-80.30866,{"facility":136,"status":8,"city":137,"state":97,"zip":138,"country":67,"contacts":139,"geoPoint":145},"American Research Centers of FL","Pembroke Pines","33027",[140,143],{"name":141,"role":71,"email":142},"Liliana Portal","lportal@americanresearchcenters.com",{"name":144,"role":76},"Luis Del Prado Rodriguez",{"lat":146,"lon":147},26.00315,-80.22394,{"facility":149,"status":8,"city":150,"state":97,"zip":151,"country":67,"contacts":152,"geoPoint":158},"Cen Exel FCR","Tampa","33613",[153,156],{"name":154,"role":71,"email":155},"Kaylie Locascio","k.locascio@cenexel.com",{"name":157,"role":76},"Deborah White",{"lat":159,"lon":160},27.94752,-82.45843,{"facility":162,"status":8,"city":163,"state":97,"zip":164,"country":67,"contacts":165,"geoPoint":172},"Cardiology Partners Clinical Research Institute","Wellington","33449",[166,170],{"name":167,"role":71,"phone":168,"email":169},"Hiromi Hauserman","+1 561 537 4778","hiromi.hauserman@cardiologypartnerspl.com",{"name":171,"role":76},"Neerav Suresh Shah",{"lat":173,"lon":174},26.65868,-80.24144,{"facility":176,"status":8,"city":177,"state":178,"zip":179,"country":67,"contacts":180,"geoPoint":187},"Javara Research","Fayetteville","Georgia","30214",[181,185],{"name":182,"role":71,"phone":183,"email":184},"Shemeka Williams","229 518 4947","swilliams@javararesearch.com",{"name":186,"role":76},"William Cooper",{"lat":188,"lon":189},33.44873,-84.45493,{"facility":191,"status":8,"city":192,"state":193,"zip":194,"country":67,"contacts":195,"geoPoint":201},"Eagle Clinical Research","Chicago","Illinois","60621",[196,199],{"name":197,"role":71,"email":198},"Iesha Griffin","igriffin@eagleclinicalresearch.com",{"name":200,"role":76},"Olalekan Sowade",{"lat":202,"lon":203},41.85003,-87.65005,{"facility":205,"status":8,"city":206,"state":207,"zip":208,"country":67,"contacts":209,"geoPoint":215},"Alliance for Multispecialty Research","Wichita","Kansas","67207",[210,213],{"name":211,"role":71,"email":212},"Layla Maxwell","layla.maxwell@amr-clinical.com",{"name":214,"role":76},"Jerry Punch",{"lat":216,"lon":217},37.69224,-97.33754,{"facility":219,"status":8,"city":220,"state":221,"zip":222,"country":67,"contacts":223,"geoPoint":229},"Anderson Medical Research","Ft. Washington","Maryland","20744",[224,227],{"name":225,"role":71,"email":226},"Ann-Marie Cobb","andersonmedicalresearch@gmail.com",{"name":228,"role":76},"Felton Anderson",{"lat":230,"lon":231},38.70734,-77.02303,{"facility":233,"status":8,"city":234,"state":235,"zip":236,"country":67,"contacts":237,"geoPoint":244},"Oakland Medical Research Center","Troy","Michigan","48085",[238,242],{"name":239,"role":71,"phone":240,"email":241},"Julie Lafave","+1 248 828 7500","jlafave@oaklandmedicalresearch.com",{"name":243,"role":76},"Jay Sandberg",{"lat":245,"lon":246},42.60559,-83.14993,{"facility":248,"status":8,"city":249,"state":250,"zip":251,"country":67,"contacts":252,"geoPoint":258},"Jefferson City Medical Group","Jefferson City","Missouri","65109",[253,256],{"name":254,"role":71,"email":255},"Suzin Cunningham","suzin.cunningham@avacare.com",{"name":257,"role":76},"George Carr",{"lat":259,"lon":260},38.5767,-92.17352,{"facility":262,"status":8,"city":263,"state":264,"zip":265,"country":67,"contacts":266,"geoPoint":273},"CenExel HRI","Berlin","New Jersey","08009",[267,271],{"name":268,"role":71,"phone":269,"email":270},"Danielle Brudon","+1 856 452 9901#802","d.brudon@cenexel.com",{"name":272,"role":76},"Kyle Coupe",{"lat":274,"lon":275},39.79123,-74.92905,{"facility":277,"status":8,"city":278,"state":279,"zip":280,"country":67,"contacts":281,"geoPoint":288},"Monroe Biomedical Research","Monroe","North Carolina","28112",[282,286],{"name":283,"role":71,"phone":284,"email":285},"Maya Patterson","+1 704 283 7359","Maya.Patterson@monroeresearch.com",{"name":287,"role":76},"Awawu Igbinadolor",{"lat":289,"lon":290},34.98543,-80.54951,{"facility":292,"status":8,"city":293,"state":294,"zip":295,"country":67,"contacts":296,"geoPoint":302},"Conrad Clinical Research","Edmond","Oklahoma","73013",[297,300],{"name":298,"role":71,"email":299},"Shelly Todd","stodd@oktrials.com",{"name":301,"role":76},"Vicki Conrad",{"lat":303,"lon":304},35.65283,-97.4781,{"facility":306,"status":8,"city":307,"state":308,"zip":309,"country":67,"contacts":310,"geoPoint":317},"Clinical Neuroscience Solutions Inc","Memphis","Tennessee","38119",[311,315],{"name":312,"role":71,"phone":313,"email":314},"Melissa Flowers","+1 901 843 1045","mflowers@cnshealthcare.com",{"name":316,"role":76},"Lora J. McGill",{"lat":318,"lon":319},35.14953,-90.04898,{"facility":321,"status":8,"city":322,"state":323,"zip":324,"country":67,"contacts":325,"geoPoint":331},"Sun Research Institute","San Antonio","Texas","78205",[326,329],{"name":327,"role":71,"email":328},"Chandana Gagireddy","cgagireddy@sunresearch.com",{"name":330,"role":76},"Leonel Reyes",{"lat":332,"lon":333},29.42412,-98.49363,{"facility":335,"status":8,"city":336,"state":337,"zip":338,"country":339,"geoPoint":340},"Novartis Investigative Site","Suita","Osaka","5650853","Japan",{"lat":341,"lon":342},34.76143,135.51567,{"facility":335,"status":8,"city":344,"state":345,"zip":346,"country":339},"Chuo Ku","Tokyo","104-0031",{"facility":335,"status":8,"city":348,"state":345,"zip":349,"country":339},"Chuo-ku","1030027",{"facility":335,"status":8,"city":351,"state":345,"zip":352,"country":339},"Shinjuku Ku","160-0008",{"facility":335,"status":8,"city":354,"zip":355,"country":354,"geoPoint":356},"Singapore","119074",{"lat":357,"lon":358},1.28967,103.85007,{"facility":335,"status":8,"city":354,"zip":360,"country":354,"geoPoint":361},"529889",{"lat":357,"lon":358},[363,366],{"name":13,"role":71,"phone":364,"email":365},"1-888-669-6682","novartis.email@novartis.com",{"name":13,"role":71,"phone":367},"+41613241111",[369],{"name":13,"affiliation":13,"role":370},"STUDY_DIRECTOR",[],[],{"nct_id":4,"conditions":374,"biomarkers":375},[21],[],{"nct_id":4,"found":53,"summary":52,"prompt_version":52}]